Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals    

Global Biopharmaceuticals Market Research Report

Biopharmaceuticals and its peer markets - Drug Discovery & Development Outsourcing, Drug formulations, Immunoassay, Pharmaceutical Films, Wireless Health, Chromatography, Digital Pathology, Radiopharmaceuticals, Contract Research Organization (CRO) and 8 other markets - adds up to total Pharmaceuticals market.

Biopharmaceuticals can be segmented by Submarkets, Products, Ingredients and Technologies. Submarkets of this market are Chromatography, E-Clinical Trial Solutions, Wireless Health, Immunoassay, Digital Pathology, Next Generation Sequencing (NGS), NGS Platforms/Consumables/Services and Biosimilars. Products of this market are Lab-on-chips (Microfluidics) and Microreactors. Ingredients of this market are Dietary Fibers, High Intensity Sweetners (HIS) and Vitamins & Derivatives. Technologies of this market are Microfluidics.

 

Key Questions Answered

 

What makes our report unique?

  • What are market estimates and forecasts; which of Biopharmaceuticals markets are doing well and which are not?

     

    Audience for this report

    • This reports provides most granular segmentation on Chromatography, E-Clinical Trial Solutions, Wireless Health and Immunoassay.
    • This report provides market sizing and forecast for the Biopharmaceuticals market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
      • Global Biopharmaceuticals companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers
show more
PRODUCT TITLE PUBLISHED
Biosimilars Biosimilars
Biosimilars and Chromatography, E-Clinical Trial...
Upcoming
Recombinant Non-Glycosylated Proteins Recombinant Non-Glycosylated Proteins
Recombinant Non-Glycosylated Proteins and Recombinant Glycosylated Proteins and
Upcoming
Recombinant Glycosylated Proteins Recombinant Glycosylated Proteins
Recombinant Glycosylated Proteins and Recombinant Non-Glycosylated Proteins and
Upcoming
Recombinant Peptides Recombinant Peptides
Recombinant Peptides and Recombinant Non-Glycosylated Proteins and
Upcoming
Insulin Insulin
Insulin and Recombinant Human Growth Hormone (RHGH),
Upcoming
Recombinant Human Growth Hormone (RHGH) Recombinant Human Growth Hormone (RHGH)
Recombinant Human Growth Hormone (RHGH) and Insulin,
Upcoming
Granulocyte Colony-Stimulating Factor (Filgrastim) Granulocyte Colony-Stimulating Factor (Filgrastim)
Granulocyte Colony-Stimulating Factor (Filgrastim) and Insulin,
Upcoming
Interferon Biosimilars Interferon Biosimilars
Interferon Biosimilars and Insulin, Recombinant Human...
Upcoming
Erythropoietin (EPO) Erythropoietin (EPO)
Erythropoietin (EPO) and Monoclonal Antibodies (MAB) and
Upcoming
Monoclonal Antibodies (MAB) Monoclonal Antibodies (MAB)
Monoclonal Antibodies (MAB) and Erythropoietin (EPO) and
Upcoming
Follitropin Follitropin
Follitropin and Erythropoietin (EPO) and Monoclonal...
Upcoming
Glucagon Glucagon
Glucagon and Calcitonin adds up to total Recombinant Peptides...
Upcoming
Calcitonin Calcitonin
Calcitonin and Glucagon adds up to total Recombinant Peptides...
Upcoming
Israel Biopharmaceuticals Israel Biopharmaceuticals
The Israel bio-pharma research market is expected to grow at a CAGR of 7.4% to reach USD 659.2 million by 2020. Increasing number of pharmaceutical and biotechnology start-ups, government support, availability of sufficient venture capital (VC) funds, and availability of skilled, educated, and diverse workforce are the major factors driving the Israel medical devices market. However, government regulations (such as drug pricing) are the major factors restraining the growth of this market.
Nov 2015
14 of 14 items
14 reports | Show
Connect With Us
US/CAN : +1-888-502-0539